Approval · Notice of Compliance 31049 · 2023
TISSUEBLUE: Notice of Compliance 31049
Issued June 23, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31049
- Date
- June 23, 2023
- Company
- Dutch Ophthalmic Research Center International BvZuidland, Zuid-Holland, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate supplier of the buffered NaCl solution excipient
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TISSUEBLUE | Not yet assigned | — |
Medicinal ingredients
- BRILLIANT BLUE G 0.25 MG per ML